Literature DB >> 11876654

Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.

Chun-Nam Lok1, Ekaterina Viazovkina, Kyung-Lyum Min, Eva Nagy, Christopher J Wilds, Masad J Damha, Michael A Parniak.   

Abstract

Phosphorothioate deoxyribonucleotides (PS-DNA) are among the most widely used antisense inhibitors. PS-DNA exhibits desirable properties such as enhanced nuclease resistance, improved bioavailability, and the ability to induce RNase H mediated degradation of target RNA. Unfortunately, PS-DNA possesses a relatively low binding affinity for target RNA that impacts on its potency in antisense applications. We recently showed that phosphodiester-linked oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinonucleic acid (FANA) exhibit both high binding affinity for target RNA and the ability to elicit RNase H degradation of target RNA [Damha et al. (1998) J. Am. Chem. Soc. 120, 12976]. In the present study, we evaluated the antisense activity of phosphorothioate-linked FANA oligonucleotides (PS-FANA). Oligonucleotides comprised entirely of PS-FANA were somewhat less efficient in directing RNase H cleavage of target RNA as compared to their phosphorothioate-linked DNA counterparts, and showed only weak antisense inhibition of cellular target expression. However, mixed-backbone oligomers comprised of PS-FANA flanking a central core of PS-DNA were found to possess potent antisense activity, inhibiting specific cellular gene expression with EC(50) values of less than 5 nM. This inhibition was a true antisense effect, as indicated by the dose-dependent decrease in both target protein and target mRNA. Furthermore, the appearance of mRNA fragments was consistent with RNase H mediated cleavage of the mRNA target. We also compared a series of PS-[FANA-DNA-FANA] mixed-backbone oligomers of varying PS-DNA core sizes with the corresponding 2'-O-methyl oligonucleotide chimeras, i.e., PS-[2'meRNA-DNA-2'meRNA]. Both types of oligomers showed very similar binding affinities toward target RNA. However, the antisense potency of the 2'-O-methyl chimeric compounds was dramatically attenuated with decreasing DNA core size, whereas that of the 2'-fluoroarabino compounds was essentially unaffected. Indeed, a PS-FANA oligomer containing a single deoxyribonucleotide residue core retained significant antisense activity. These findings correlated exactly with the ability of the various chimeric antisense molecules to elicit RNase H degradation of the target RNA in vitro, and suggest that this mode of inhibition is likely the most important determinant for potent antisense activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876654     DOI: 10.1021/bi0115075

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

Review 1.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

2.  Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.

Authors:  William H Thiel; Carla L Esposito; David D Dickey; Justin P Dassie; Matthew E Long; Joshua Adam; Jennifer Streeter; Brandon Schickling; Maysam Takapoo; Katie S Flenker; Julia Klesney-Tait; Vittorio de Franciscis; Francis J Miller; Paloma H Giangrande
Journal:  Mol Ther       Date:  2016-01-06       Impact factor: 11.454

3.  2'-Fluoroarabino- and arabinonucleic acid show different conformations, resulting in deviating RNA affinities and processing of their heteroduplexes with RNA by RNase H.

Authors:  Feng Li; Sanjay Sarkhel; Christopher J Wilds; Zdzislaw Wawrzak; Thazha P Prakash; Muthiah Manoharan; Martin Egli
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

4.  2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing.

Authors:  A Kalota; L Karabon; C R Swider; E Viazovkina; M Elzagheid; M J Damha; A M Gewirtz
Journal:  Nucleic Acids Res       Date:  2006-01-18       Impact factor: 16.971

5.  RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.

Authors:  Margit Mutso; Andrei Nikonov; Arno Pihlak; Eva Žusinaite; Liane Viru; Anastasia Selyutina; Tõnu Reintamm; Merike Kelve; Mart Saarma; Mati Karelson; Andres Merits
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

6.  Antisense 2'-Deoxy, 2'-Fluroarabino Nucleic Acids (2'F-ANAs) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids.

Authors:  Naira Souleimanian; Glen F Deleavey; Harris Soifer; Sijian Wang; Katrin Tiemann; Masad J Damha; Cy A Stein
Journal:  Mol Ther Nucleic Acids       Date:  2012-09-18       Impact factor: 10.183

7.  Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA).

Authors:  Thomas Dowler; Denis Bergeron; Anna-Lisa Tedeschi; Luc Paquet; Nicolay Ferrari; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2006-03-22       Impact factor: 16.971

8.  2'-fluoro-4'-thioarabino-modified oligonucleotides: conformational switches linked to siRNA activity.

Authors:  Jonathan K Watts; Niloufar Choubdar; Kashinath Sadalapure; Francis Robert; Alexander S Wahba; Jerry Pelletier; B Mario Pinto; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2007-02-06       Impact factor: 16.971

9.  Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.

Authors:  Louise Carøe Vohlander Rasmussen; Hans Uffe Sperling-Petersen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2007-08-10       Impact factor: 5.328

10.  G-quadruplex induced stabilization by 2'-deoxy-2'-fluoro-D-arabinonucleic acids (2'F-ANA).

Authors:  Chang Geng Peng; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2007-07-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.